{"id":2965,"date":"2019-06-10T01:41:00","date_gmt":"2019-06-10T06:41:00","guid":{"rendered":"https:\/\/worldcarenew.wpenginepowered.com\/?p=2965"},"modified":"2026-03-08T02:23:44","modified_gmt":"2026-03-08T07:23:44","slug":"ucla-descopera-o-noua-optiune-de-tratament-pentru-pacientii-cu-cancer-pulmonar","status":"publish","type":"post","link":"https:\/\/www.worldcare.com\/ro\/ucla-finds-new-treatment-option-for-lung-cancer-patients\/","title":{"rendered":"UCLA g\u0103se\u0219te o nou\u0103 op\u021biune de tratament pentru pacien\u021bii cu cancer pulmonar"},"content":{"rendered":"<p>Putem spune cu siguran\u021b\u0103 c\u0103 mul\u021bi dintre noi ne temem s\u0103 auzim cuv\u00e2ntul \u2018cancer\u2019. Dar, odat\u0103 cu evolu\u021bia continu\u0103 a cercet\u0103rii \u00een domeniul cancerului, am \u00eenceput s\u0103 vedem multe progrese \u00een metodele de tratament \u0219i detectare a cancerului. Un astfel de exemplu este cel al Dr. David Wong, decan asociat de cercetare, \u0219i al echipei sale, de la\u00a0<a href=\"https:\/\/www.worldcare.com\/ro\/abordarea-noastra\/\">Consor\u021biul WorldCare<sup>\u00ae<\/sup><\/a>\u00a0furnizor de servicii de a doua opinie medical\u0103 (MSO)\u00a0<a href=\"http:\/\/www.uclahealth.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">UCLA Health<\/a>, o nou\u0103 tehnologie de biopsie lichid\u0103. Aceast\u0103 nou\u0103 tehnologie, care a primit recent aprobarea de reglementare, poate detecta formele timpurii de cancer pulmonar \u0219i se nume\u0219te eliberare \u0219i m\u0103surare indus\u0103 de c\u00e2mp electric (EFIRM). Deci, ce este exact EFIRM \u0219i ce o face at\u00e2t de revolu\u021bionar\u0103?<\/p>\n\n\n\n<p>EFIRM este o procedur\u0103 neinvaziv\u0103 care ofer\u0103 o metod\u0103 sigur\u0103, fiabil\u0103, nou\u0103 \u0219i eficient\u0103 pentru detectarea muta\u021biilor cancerului pulmonar care cauzeaz\u0103 tumori \u00een salvie \u0219i s\u00e2nge. Aceast\u0103 metod\u0103 poate depista semne precoce ale cancerului \u0219i ajut\u0103 medicul s\u0103 ajusteze strategiile terapeutice, precum \u0219i s\u0103 \u00eembun\u0103t\u0103\u021beasc\u0103 rezultatele clinice.<\/p>\n\n\n\n<p>Cu eforturi din partea&nbsp;<a href=\"https:\/\/www.cancer.gov\/\" target=\"_blank\" rel=\"noreferrer noopener\">Institutul Na\u021bional al Cancerului<\/a>&nbsp;Dr. Wong \u0219i colegii s\u0103i cercet\u0103tori au primit o subven\u021bie de $2.5 milioane \u00een 2017, ceea ce le-a permis s\u0103 avanseze cu succes \u00een faza de testare mai rapid. Tratamentul a fost aprobat pentru utilizare \u00een cabinetele medicale. O alt\u0103 subven\u021bie de $5 milioane din partea&nbsp;<a href=\"https:\/\/www.cancer.gov\/\" target=\"_blank\" rel=\"noreferrer noopener\">Institutul Na\u021bional al Cancerului<\/a>&nbsp;a fost realizat \u00een octombrie 2018 pentru a fi utilizat pe o perioad\u0103 de cinci ani. Acesta a fost folosit pentru a continua eforturile de dezvoltare \u0219i rafinare a tehnologiei. Dup\u0103 testarea acesteia pe 300 de pacien\u021bi cu cancer pulmonar, s-a demonstrat c\u0103 este esen\u021bial\u0103 \u00een detectarea precoce a cancerului. \u00centr-at\u00e2t \u00eenc\u00e2t peste 90% dintre pacien\u021bi au putut fi testa\u021bi pentru stadii incipiente ale cancerului pulmonar, comparabil cu biopsiile tradi\u021bionale de \u021besuturi. \u00cen efortul de a promova aceste descoperiri, Dr. Wong a fost invitat s\u0103 vorbeasc\u0103 la sesiunea sponsorizat\u0103 de NCI din 2 aprilie 2019, la reuniunea anual\u0103 pentru&nbsp;<a href=\"https:\/\/www.aacr.org\/Pages\/Home.aspx\" target=\"_blank\" rel=\"noreferrer noopener\">Asocia\u021bia American\u0103 pentru Cercetarea Cancerului<\/a>&nbsp;(AACR). \u00cen timpul prezent\u0103rii sale, el a discutat importan\u021ba biopsiilor lichide pentru sute de cercet\u0103tori \u00een domeniul cancerului.<\/p>\n\n\n\n<p>Mai este mult de parcurs, dar pa\u0219ii pozitivi \u0219i impactul acestei tehnologii \u0219i al altor cercet\u0103ri ne aduc mult mai aproape de detectarea timpurie \u0219i de posibile vindec\u0103ri. Dac\u0103 a\u021bi fost diagnosticat cu cancer pulmonar \u00een stadiu incipient sau crede\u021bi c\u0103 medicul dumneavoastr\u0103 a ratat un diagnostic at\u00e2t de important,&nbsp;<a href=\"https:\/\/www.worldcare.com\/ro\/contact\/\">Contacta\u021bi-ne ast\u0103zi<\/a>&nbsp;pentru o a doua opinie medical\u0103.<\/p>\n\n\n\n<p><strong>Surs\u0103:<\/strong>&nbsp;<a href=\"https:\/\/www.uclahealth.org\/early-cancer-detection-liquid-biopsy-technology-receives-regulatory-approval\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.uclahealth.org\/early-cancer-detection-liquid-biopsy-technology-receives-regulatory-approval<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>It is safe to say that many of us fear hearing the word \u2018cancer.\u2019 But, with the continued evolution of cancer research, we have begun to see many breakthroughs in cancer treatment and detection methods. One such example is Dr. David Wong\u2019s, Associate Dean of Research and his team\u2019s, at\u00a0WorldCare Consortium\u00ae\u00a0medical second opinion (MSO) provider\u00a0UCLA [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2966,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[46,126,125,85,122],"class_list":["post-2965","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-cancer","tag-lung-cancer","tag-medical-innovation","tag-oncology","tag-treatment-research"],"_links":{"self":[{"href":"https:\/\/www.worldcare.com\/ro\/wp-json\/wp\/v2\/posts\/2965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.worldcare.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.worldcare.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/ro\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/ro\/wp-json\/wp\/v2\/comments?post=2965"}],"version-history":[{"count":0,"href":"https:\/\/www.worldcare.com\/ro\/wp-json\/wp\/v2\/posts\/2965\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/ro\/wp-json\/wp\/v2\/media\/2966"}],"wp:attachment":[{"href":"https:\/\/www.worldcare.com\/ro\/wp-json\/wp\/v2\/media?parent=2965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.worldcare.com\/ro\/wp-json\/wp\/v2\/categories?post=2965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.worldcare.com\/ro\/wp-json\/wp\/v2\/tags?post=2965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}